TRACK 1: Inspiring Innovation in Formulation, Bioprocessing, and Drug Delivery

(T0930-01-01) Lipid Nanoparticle Morphology and Phase Transitions Investigated through Small Angle X-Ray Scattering and Contrast Variation in a Laboratory Instrument

(M0930-01-02) Exploring the Impact of Iron Availability on Morphology and Antibiotic Resistance in Mycobacterium Species

(T0930-01-02) Investigating the Effects of Multi-Drug-Loaded Nanospheres in Enhancing Antitumor Efficacy and Augmenting Immune Response Against Metastatic Melanoma

(M0930-01-03) Antiproliferative Effects of Low Level Light-Low Dose Magnetic Nanoparticle Exposure on Human Umbilical Vein Endothelial Cells

(T0930-01-03) Formulation and Evaluation of Silymarin Proniosomes for Enhanced Solubility, Bioavailability, and Therapeutic Efficacy

(M0930-01-04) Macroporous Granular Nanocomposite Hydrogels for Controlled Oligonucleotide Delivery

(T0930-01-04) Zinc-Associated Peptide Coacervates for Recombinant Protein Capture and Release

(M0930-01-05) Modernization of Compendial Size-Exclusion Chromatography Aggregation Analysis Methods in Compliance with Updates to USP General Chapter < 129 >

(T0930-01-05) Preclinical Subcutaneous Injectability and Local Tolerability of an Antibody-Drug Conjugate Delivered with Recombinant Human Hyaluronidase PH20 Using a Handheld High-Volume Auto-Injector

(M0930-02-06) Investigations into the Effects of Protein Corona Formation on Novel Polymeric Nanoparticle Systems

(M1030-01-01) Development of Improved Chromatographic Methods for the Separation of Synthetic Peptide Medications and Associated Impurities

(T1030-01-01) Using Flow Imaging Microscopy to Meet Particulate Matter Standards for Biotherapeutics

(T1030-01-02) Blueberry-Derived Exosomes as a Natural miRNA Delivery System for the Treatment of Neurodegenerative Diseases

(M1030-01-02) Using Novel Light Scattering Technology for Expedited Biologics Stability Assessment:  Implications for Successful Development and Manufacturing

(T1030-01-03) ATR-FTIR Spectroscopy as an Orthogonal Method for Secondary Structure Characterization of Monoclonal Antibodies Under Thermal Stress

(M1030-01-03) High-Throughput Viscometry with Injectability Screening of High Concentration Protein Formulations by Multiplexed Microfluidic Quartz Resonators

(T1030-01-04) Development of Polymer-Based miRNA Delivery System for CXCR4 Inhibition and miR155 Inhibition in Target Cells in the Liver to Treat Alcohol-Associated Liver Disease

(M1030-01-04) Impact of Handling and Transfer on Aggregation of a Trastuzumab Biosimilar in an In-Use Study

(M1030-01-05) Evaluating the Immunomodulatory Efficacy of an Ethanolic Spray-Dried Extract of Spirulina

(T1030-01-05) GCMS Analysis of Bioactive Compounds of Extracted Growth Hormone Concentration (Auxin) and Antimicrobial Activity of Pentas lanceolata and Chrysanthemum Morifolium: An Ornamental Flowering Plants

(T1030-02-07) Viscosity Reduction of an IgG1 Antibody via Hydrogen-Deuterium Exchange Mass Spectrometry-Augmented Protein Engineering

(M1230-01-01) Generating Novel Linker Sequences in Antibody-Drug Conjugates with Diffusion Models

(T1230-01-01) Mutagenic NDSRI of Citalopram - Critical Structural Evaluation of Carcinogenic Category and Development of a Highly Sensitive LC-MS/MS Method Development for Quantification

(M1230-01-02) Additivity of Transfer Free Energies Enables Description of Complex Protein Formulations in Implicit Solvent Molecular Dynamics Simulations

(T1230-01-02) Rapid Diagnostics Redefined: The Power of Point-of-Care Testing

(T1230-01-03) Break Loose Force and Glide Force Evaluation of Various Container Closure System Combination for Empty Syringe

(M1230-01-03) Pegylation Enhanced Mucin Penetration of Biotinylated PLGA Nanoparticles

(T1230-01-04) Application of Experimentally Derived Hansen Solubility Parameters to Optimize Amorphous Solid Dispersion Formulation

(M1230-01-04) Engineering ‘Eat Me’ Signals for LNPs to Enhance mRNA Cancer Vaccination

(M1230-01-05) Comparison of Commonly Used Hydrophilic Polymers for Matrix Tablet Formulation and Evaluation of Drug Release in Hydro-Alcoholic Media

(T1230-01-05) Impact of Excipient Composition on the Stability of Trastuzumab Biosimilars

(T1330-01-01) ROS-Responsive Mucoadhesive Pro-drug with Mesalazine for Curing Inflammatory Bowel Disease

(M1330-01-01) Utility of Small Angle X-Ray Scattering (SAXS) in Process Development, Characterization and Comparability of Lipid Nanoparticles, Liposomes and Fusion Proteins

(T1330-01-02) Optimizing Gel Network Architecture for Oxanorbornadiene-Based Degradable Hydrogels

(M1330-01-03) Engineering Extended-Release Profiles for Biologic Drugs via Chemical Crosslinking of Poloxamer 407 Hydrogels

(T1330-01-04) Platform Formulation Approach for Injectable GalNAc siRNA

(M1330-01-05) Mitigation of Doxorubicin-Induced Cardiotoxicity and Chemosensitization Using Combination Phytochemicals in Polymeric Micelles

(T1430-01-01) 3-D Printed Rapidly Disintegrating Oral Films for Targeted Delivery of Aspirin in the Brain for Ischemic Stroke

(M1430-01-01) Nanocapsules for Combined Delivery of Docetaxel and Laguncularia Racemosa Extract Against Oral Cancer Cells In Vitro

(T1430-01-02) Insights from Drug Development Experts: Surveying Challenges and Outcomes for Large-Volume Subcutaneous Oncology Drugs

(M1430-01-02) Revolutionizing Ocular Drug Delivery: Prolonged Sunitinib Release from Elastomeric Biodegradable Injectable Tiny Implants for Treatment of Diabetic Retinopathy

(M1430-01-03) Enhanced Membrane Composition for Lipid Nanoparticle Vascular Drug Delivery

(T1430-01-03) Importance of Early-Stage Process Design Space Assessment for Lipid Nanoparticles (LNP) Technology Transfer

(M1430-01-04) Implementing siRNA Therapy Targeted at MLL-AF4 in Acute Lymphoblastic Leukemia

(T1430-01-04) Long-Term Storage of Targeted Lipid Nanoparticles for Vascular Gene Therapies

(T1430-01-05) Rapid and Precise Detection of Mutations in Extracellular Vesicle DNA Using a Liposome-Based CRISPR-Cas12a System

(M1430-01-05) Running at the Verge of Collapse in Lyophilization: What is the Impact of the Edge Vial Effect on Protein Stability and Particle Morphology?